Globe Life (NYSE:GL) Stock Price Expected to Rise, Truist Financial Analyst Says

Globe Life (NYSE:GL) had its price objective raised by Truist Financial from $158.00 to $180.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s price target suggests a potential upside of 22.77% from the stock’s previous close.

A number of other equities analysts also recently weighed in on the company. Weiss Ratings downgraded Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, January 14th. Piper Sandler reissued an “overweight” rating and set a $167.00 price target on shares of Globe Life in a research report on Friday, November 21st. JPMorgan Chase & Co. boosted their price target on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday. TD Cowen reiterated a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Finally, Wells Fargo & Company dropped their price objective on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Seven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $171.00.

Globe Life Price Performance

GL opened at $146.62 on Friday. The stock has a market cap of $11.67 billion, a P/E ratio of 10.41 and a beta of 0.47. Globe Life has a 12 month low of $109.38 and a 12 month high of $152.71. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. The company has a fifty day simple moving average of $139.38 and a 200 day simple moving average of $138.08.

Globe Life (NYSE:GL) last posted its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the firm posted $3.14 earnings per share. The firm’s revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, research analysts expect that Globe Life will post 13.87 EPS for the current year.

Insiders Place Their Bets

In other Globe Life news, CEO Frank M. Svoboda sold 9,379 shares of Globe Life stock in a transaction on Tuesday, December 16th. The stock was sold at an average price of $140.43, for a total value of $1,317,092.97. Following the completion of the transaction, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at $5,036,943.24. The trade was a 20.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.51% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Globe Life

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Mather Group LLC. acquired a new position in Globe Life during the third quarter worth about $28,000. CYBER HORNET ETFs LLC bought a new stake in shares of Globe Life during the second quarter worth about $28,000. Assetmark Inc. increased its stake in shares of Globe Life by 777.8% in the second quarter. Assetmark Inc. now owns 237 shares of the company’s stock valued at $29,000 after buying an additional 210 shares during the period. MUFG Securities EMEA plc bought a new position in Globe Life in the 2nd quarter valued at approximately $31,000. Finally, Quent Capital LLC bought a new position in Globe Life in the 3rd quarter valued at approximately $36,000. 81.61% of the stock is currently owned by institutional investors.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.